Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-18-064336

Director bought 18,354 shares at an average $0.53 ($9,651)

From the SEC's structured data for this filing

Trades in this filing

HILZINGER KURT J · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2018-12-26 Purchase : show line 1 in the form +5,714 $0.54 $3,086 48,227 D
2018-12-27 Purchase : show line 2 in the form +730 $0.51 $372 48,957 D
2018-12-28 Purchase : show line 3 in the form +11,910 $0.52 $6,193 60,867 D
Open-market purchases · 18,354 sh · avg $0.53 · $9,651
Loading xslF345X03/doc4.xml…